OneAscent Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Buy
1,007
+22
+2% +$5.13K 0.08% 141
2026
Q1
$241K Sell
985
-1
-0.1% -$233 0.08% 138
2025
Q4
$204K Sell
986
-464
-32% -$91.8K 0.07% 163
2025
Q3
$269K Buy
+1,450
New +$248K 0.09% 136
2024
Q4
Sell
-1,255
Closed -$203K 174
2024
Q3
$203K Buy
+1,255
New +$200K 0.08% 175
2023
Q2
Sell
-1,959
Closed -$304K 148
2023
Q1
$304K Sell
1,959
-441
-18% -$71.2K 0.12% 121
2022
Q4
$424K Sell
2,400
-16
-0.7% -$2.76K 0.2% 61
2022
Q3
$395K Buy
2,416
+35
+1% +$5.92K 0.21% 57
2022
Q2
$423K Sell
2,381
-121
-5% -$21.6K 0.22% 68
2022
Q1
$443K Buy
+2,502
New +$426K 0.22% 89
2021
Q1
$304K Buy
1,847
+464
+34% +$75.1K 0.13% 164
2020
Q4
$218K Buy
+1,383
New +$204K 0.1% 184

Other funds holding JNJ

OneAscent Wealth Management's JNJ Position: Q2 2026 in Review

OneAscent Wealth Management increased its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, buying an estimated $5.13K and bringing the position to 1,007 shares worth $256K. The position accounts for 0.08% of the portfolio, ranked #141.

OneAscent Wealth Management first reported a position in JNJ in Q4 2020 and has held it in 12 quarters since. The position peaked at $443K in Q1 2022. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • OneAscent Wealth Management held 1,007 shares of Johnson & Johnson worth $256K as of Q2 2026.
  • OneAscent Wealth Management bought 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
  • Johnson & Johnson made up 0.08% of OneAscent Wealth Management's portfolio in Q2 2026, its #141 holding.
  • OneAscent Wealth Management first reported a position in Johnson & Johnson in Q4 2020 and has held it in 12 quarters since.
  • OneAscent Wealth Management's Johnson & Johnson position peaked at $443K in Q1 2022.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on OneAscent Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.